Found: 58
Select item for more details and to access through your institution.
Nonhuman primates exposed to Zika virus in utero are not protected against reinfection at 1 year postpartum.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 567, p. 1, doi. 10.1126/scitranslmed.aaz4997
- By:
- Publication type:
- Article
Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 550, p. 1, doi. 10.1126/scitranslmed.abc3539
- By:
- Publication type:
- Article
Insect cell expression and purification of recombinant SARS‐COV‐2 spike proteins that demonstrate ACE2 binding.
- Published in:
- Protein Science: A Publication of the Protein Society, 2022, v. 31, n. 5, p. 1, doi. 10.1002/pro.4300
- By:
- Publication type:
- Article
CyDisCo production of functional recombinant SARS‐CoV‐2 spike receptor binding domain.
- Published in:
- Protein Science: A Publication of the Protein Society, 2021, v. 30, n. 9, p. 1983, doi. 10.1002/pro.4152
- By:
- Publication type:
- Article
Protective antigenic sites in respiratory syncytial virus G attachment protein outside the central conserved and cysteine noose domains.
- Published in:
- PLoS Pathogens, 2018, v. 14, n. 8, p. 1, doi. 10.1371/journal.ppat.1007262
- By:
- Publication type:
- Article
Antigenic Fingerprinting following Primary RSV Infection in Young Children Identifies Novel Antigenic Sites and Reveals Unlinked Evolution of Human Antibody Repertoires to Fusion and Attachment Glycoproteins.
- Published in:
- PLoS Pathogens, 2016, v. 12, n. 4, p. 1, doi. 10.1371/journal.ppat.1005554
- By:
- Publication type:
- Article
Comparison of SARS-CoV-2 Hyperimmune Immunoglobulins Following Infection Plus Vaccination vs Infection.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 8, p. e2327307, doi. 10.1001/jamanetworkopen.2023.27307
- By:
- Publication type:
- Article
Antibody affinity and cross-variant neutralization of SARS-CoV-2 Omicron BA.1, BA.2 and BA.3 following third mRNA vaccination.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32298-w
- By:
- Publication type:
- Article
Autoreactivity of Broadly Neutralizing Influenza Human Antibodies to Human Tissues and Human Proteins.
- Published in:
- Viruses (1999-4915), 2020, v. 12, n. 10, p. 1140, doi. 10.3390/v12101140
- By:
- Publication type:
- Article
A Live Attenuated Influenza A(H5N1) Vaccine Induces Long-Term Immunity in the Absence of a Primary Antibody Response.
- Published in:
- Journal of Infectious Diseases, 2014, v. 209, n. 12, p. 1860, doi. 10.1093/infdis/jiu123
- By:
- Publication type:
- Article
DNA priming prior to inactivated influenza A(H5N1) vaccination expands the antibody epitope repertoire and increases affinity maturation in a boost-interval-dependent manner in adults.
- Published in:
- 2013
- By:
- Publication type:
- journal article
DNA Priming Prior to Inactivated Influenza A(H5N1) Vaccination Expands the Antibody Epitope Repertoire and Increases Affinity Maturation in a Boost-Interval–Dependent Manner in Adults.
- Published in:
- Journal of Infectious Diseases, 2013, v. 208, n. 3, p. 413, doi. 10.1093/infdis/jit178
- By:
- Publication type:
- Article
Heterovariant Cross-Reactive B-Cell Responses Induced by the 2009 Pandemic Influenza Virus A Subtype H1N1 Vaccine.
- Published in:
- Journal of Infectious Diseases, 2013, v. 207, n. 2, p. 288, doi. 10.1093/infdis/jis664
- By:
- Publication type:
- Article
Immune Response Following H1N1pdm09 Vaccination: Differences in Antibody Repertoire and Avidity in Young Adults and Elderly Populations Stratified by Age and Gender.
- Published in:
- Journal of Infectious Diseases, 2012, v. 205, n. 4, p. 610, doi. 10.1093/infdis/jir791
- By:
- Publication type:
- Article
AID Activity in B Cells Strongly Correlates with Polyclonal Antibody Affinity Maturation in-vivo Following Pandemic 2009-H1N1 Vaccination in Humans.
- Published in:
- PLoS Pathogens, 2012, v. 8, n. 9, p. 1, doi. 10.1371/journal.ppat.1002920
- By:
- Publication type:
- Article
Genome‐wide association analysis of COVID‐19 mortality risk in SARS‐CoV‐2 genomes identifies mutation in the SARS‐CoV‐2 spike protein that colocalizes with P.1 of the Brazilian strain.
- Published in:
- Genetic Epidemiology, 2021, v. 45, n. 7, p. 685, doi. 10.1002/gepi.22421
- By:
- Publication type:
- Article
AS03-adjuvanted H5N1 vaccine promotes antibody diversity and affinity maturation, NAI titers, cross-clade H5N1 neutralization, but not H1N1 cross-subtype neutralization.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0076-2
- By:
- Publication type:
- Article
Evolution of the Antigenic Landscape in Children and Young Adults with COVID-19 and MIS-C.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 638, doi. 10.3390/vaccines12060638
- By:
- Publication type:
- Article
Immune Response to SARS-CoV-2 Vaccine and Following Breakthrough Omicron Infection in an Autoimmune Patient with Hashimoto's Thyroiditis, Pernicious Anemia, and Chronic Atrophic Autoimmune Gastritis: A Case Report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Systemic and Lower Respiratory Tract Immunity to SARS-CoV-2 Omicron and Variants in Pediatric Severe COVID-19 and Mis-C.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 270, doi. 10.3390/vaccines10020270
- By:
- Publication type:
- Article
Development and Regulation of Novel Influenza Virus Vaccines: A United States Young Scientist Perspective.
- Published in:
- 2018
- By:
- Publication type:
- Other
Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-21463-2
- By:
- Publication type:
- Article
Reply to Focosi et al.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Severe Acute Respiratory Syndrome Coronavirus 2 Hyperimmune Intravenous Human Immunoglobulins Neutralizes Omicron Subvariants BA.1, BA.2, BA.2.12.1, BA.3, and BA.4/BA.5 for Treatment of Coronavirus Disease 2019.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 3, p. e503, doi. 10.1093/cid/ciac642
- By:
- Publication type:
- Article
Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron and Other Variants in Serum From Children With Vaccination-Induced Myocarditis.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 9, p. 1645, doi. 10.1093/cid/ciac323
- By:
- Publication type:
- Article
Pharmacokinetics and Efficacy of Human Hyperimmune Intravenous Immunoglobulin Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Adult Syrian Hamsters.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e459, doi. 10.1093/cid/ciab854
- By:
- Publication type:
- Article
Impact of Convalescent Plasma Therapy on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Profile in Coronavirus Disease 2019 (COVID-19) Patients.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 2, p. 327, doi. 10.1093/cid/ciab317
- By:
- Publication type:
- Article
Increased Antibody Avidity and Cross-Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Variants by Hyperimmunized Transchromosomic Bovine-Derived Human Immunoglobulins for Treatment of Coronavirus Disease 2019.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 4, p. 655, doi. 10.1093/infdis/jiac031
- By:
- Publication type:
- Article
Antigenic Fingerprinting of Respiratory Syncytial Virus (RSV)-A-Infected Hematopoietic Cell Transplant Recipients Reveals Importance of Mucosal Anti-RSV G Antibodies in Control of RSV Infection in Humans.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Antibody Repertoire of Human Polyclonal Antibodies Against Ebola Virus Glycoprotein Generated After Deoxyribonucleic Acid and Protein Vaccination of Transchromosomal Bovines.
- Published in:
- 2018
- By:
- Publication type:
- journal article
High-Affinity H7 Head and Stalk Domain-Specific Antibody Responses to an Inactivated Influenza H7N7 Vaccine After Priming With Live Attenuated Influenza Vaccine.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Immune responses and therapeutic challenges in paediatric patients with new‐onset acute myeloid leukaemia and concomitant COVID‐19.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 3, p. 549, doi. 10.1111/bjh.17517
- By:
- Publication type:
- Article
Oral Priming with Replicating Adenovirus Serotype 4 Followed by Subunit H5N1 Vaccine Boost Promotes Antibody Affinity Maturation and Expands H5N1 Cross-Clade Neutralization.
- Published in:
- PLoS ONE, 2015, v. 10, n. 1, p. 1, doi. 10.1371/journal.pone.0115476
- By:
- Publication type:
- Article
Heterologous Prime-Boost Vaccination with MF59-Adjuvanted H5 Vaccines Promotes Antibody Affinity Maturation towards the Hemagglutinin HA1 Domain and Broad H5N1 Cross-Clade Neutralization.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0095496
- By:
- Publication type:
- Article
Decreased Serologic Response in Vaccinated Military Recruits during 2011 Correspond to Genetic Drift in Concurrent Circulating Pandemic A/H1N1 Viruses.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0034581
- By:
- Publication type:
- Article
A Rapid Flp-In System for Expression of Secreted H5N1 Influenza Hemagglutinin Vaccine Immunogen in Mammalian Cells.
- Published in:
- PLoS ONE, 2011, v. 6, n. 2, p. 1, doi. 10.1371/journal.pone.0017297
- By:
- Publication type:
- Article
Properly Folded Bacterially Expressed H1N1 Hemagglutinin Globular Head and Ectodomain Vaccines Protect Ferrets against H1N1 Pandemic Influenza Virus.
- Published in:
- PLoS ONE, 2010, v. 5, n. 7, p. 1, doi. 10.1371/journal.pone.0011548
- By:
- Publication type:
- Article
Unsupervised outlier detection applied to SARS-CoV-2 nucleotide sequences can identify sequences of common variants and other variants of interest.
- Published in:
- BMC Bioinformatics, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s12859-022-05105-y
- By:
- Publication type:
- Article
Unsupervised outlier detection applied to SARS-CoV-2 nucleotide sequences can identify sequences of common variants and other variants of interest.
- Published in:
- BMC Bioinformatics, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s12859-022-05105-y
- By:
- Publication type:
- Article
Immunologic mechanisms of seasonal influenza vaccination administered by microneedle patch from a randomized phase I trial.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00353-0
- By:
- Publication type:
- Article
AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humans.
- Published in:
- Science Immunology, 2024, v. 9, n. 94, p. 1, doi. 10.1126/sciimmunol.adi8039
- By:
- Publication type:
- Article
Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infection or vaccination in children.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-43152-y
- By:
- Publication type:
- Article
Vaccine-Induced Anti-HA2 Antibodies Promote Virus Fusion and Enhance Influenza Virus Respiratory Disease.
- Published in:
- Science Translational Medicine, 2013, v. 5, n. 200, p. 1, doi. 10.1126/scitranslmed.3006366
- By:
- Publication type:
- Article
D-dimer and CoV-2 spike-immune complexes contribute to the production of PGE2 and proinflammatory cytokines in monocytes.
- Published in:
- PLoS Pathogens, 2022, v. 18, n. 4, p. 1, doi. 10.1371/journal.ppat.1010468
- By:
- Publication type:
- Article
Antigenic Fingerprinting of H5N1 Avian Influenza Using Convalescent Sera and Monoclonal Antibodies Reveals Potential Vaccine and Diagnostic Targets.
- Published in:
- PLoS Medicine, 2009, v. 6, n. 4, p. 1, doi. 10.1371/journal.pmed.1000049
- By:
- Publication type:
- Article
MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines.
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 85, p. 1, doi. 10.1126/scitranslmed.3002336
- By:
- Publication type:
- Article
Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza Virus.
- Published in:
- Science Translational Medicine, 2010, v. 2, n. 15, p. 1, doi. 10.1126/scitranslmed.3000624
- By:
- Publication type:
- Article
Influenza vaccine immunology.
- Published in:
- Immunological Reviews, 2011, v. 239, n. 1, p. 167, doi. 10.1111/j.1600-065X.2010.00974.x
- By:
- Publication type:
- Article
Comprehensive profiling of the human viral exposome in households containing an at‐risk child with mitochondrial disease during the 2020–2021 COVID‐19 pandemic.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 11, p. 1, doi. 10.1002/ctm2.1100
- By:
- Publication type:
- Article
Bromelain inhibits SARS-CoV-2 infection via targeting ACE-2, TMPRSS2, and spike protein.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 2, p. 1, doi. 10.1002/ctm2.281
- By:
- Publication type:
- Article